Extremadura awards Abbott the distribution of diabetes devices for 1.4 million
The Medtech industry reinforces the Sanitary System of Extremadura.The regional government has awarded the US company Abbott Laboratories a contract for the treatment of diabetes, which is valued at more than one million euros, as recorded in the profile of the contractor of the Executive of the Extremadura.
The company based in Illinois (United States) has been awarded a contract for the provision of a glucose measurement system for the management of the Extremadura Health Service.The Board will pay Abbott a total of 1.4 million euros for a period of one year.
The glucose monitoring technology used by Abbott eliminates the need for routine punctures on the finger to measure glucose levels.This system is indicated to measure these parameters in the interstitial fluid in people over four with diabetes mellitus.
The Free Style Glucose Monitoring Flash system, which is the name that receives this technology, has two main components: a reader and a sensor.The reader is used to wirelessly scan the sensor and obtain glucose readings in a second.
Abbott has a team formed by 103,000 people and is present in more than 160 countries around the world
ABBOTT is one of the companies referring to health care on a global scale.Its portfolio covers specialized products in the diagnostic area, medical devices, nutritional products, as well as generic medications.The Farma has a team formed by 103,000 people and is present in more than 160 countries around the world.
The American giant generated sales of 31.9 billion dollars (29,490 million euros) in 2019. of the total amount, 12,230 million dollars (11,306 million euros) come from the Medical Devices area;7,700 million dollars (7,118 million euros), diagnosis;7,400 million dollars (6,841 million euros), of the nutrition branch, and 4,486 million dollars (4,147 million euros) are of established pharmaceutical products.
Among Abbott's referent brands are glucern, a nutritious food for diabetics designed to help reduce blood glycemic response after meals;Reure, nutritional drink that helps people who cannot obtain all the necessary nutrients from food and other drinks;and Brufen, indicated by its analgesic and anti -inflammatory effects on the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still's disease).
In Spain, the laboratory has approximately 700 employees in five centers: the headquarters in Madrid, in addition to two other centers in the capital, to which the facilities of Barcelona and Granada are added.
